Today many pharmaceutical companies are competing to develop capsaicin receptor antagonists.
For after years of paying scant attention to infectious diseases, pharmaceutical companies have begun to comb through the vast chemical libraries assembled over the past decade in search of new antimicrobial agents.
The later '90s should give us gene-spliced farm animals -- hogs that yield low-cholesterol pork and cows that produce milk from which pharmaceutical companies can extract such beneficial drugs as insulin or growth hormone.